PD353 400 Pill - pink oval
Generic Name: troglitazone
Pill with imprint PD353 400 is Pink, Oval and has been identified as Rezulin 400 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Rezulin is used in the treatment of Diabetes, Type 2 and belongs to the drug class thiazolidinediones. There is no proven risk in humans during pregnancy. Rezulin 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PD353 400
Rezulin
- Generic Name
- troglitazone
- Imprint
- PD353 400
- Strength
- 400 mg
- Color
- Pink
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Thiazolidinediones
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC)
- 00071-0353 (Discontinued)
More about Rezulin (troglitazone)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- During pregnancy
- Drug class: thiazolidinediones
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
